Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (131-140 of 415) with videos related to

Pageof 42
Sort By:
AIDS (London, England)|September 16, 2015
The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIVPhilipp Kohler, Axel J Schmidt, Matthias Cavassini, et al.
BMC Infectious Diseases|July 8, 2017
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort studyDelphine Sculier, Angèle Gayet-Ageron, Manuel Battegay, et al.
AIDS (London, England)|November 21, 2007
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infectionHandan Wand, Alexandra Calmy, Dianne L Carey, et al.
AIDS (London, England)|November 30, 2020
Caring for people living with HIV during the global coronavirus disease 2019 pandemicOlivier Nawej Tshikung, Mikaela Smit, Annalisa Marinosci, et al.
American Heart Journal|December 17, 2019
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristicsFranck Boccara, Princy Kumar, Bruno Caramelli, et al.
AIDS and Behavior|June 2, 2011
Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysisOlivia Keiser, Ben Spycher, Andri Rauch, et al.
Nature Reviews. Disease Primers|July 4, 2020
Author Correction: HIV and antiretroviral therapy-related fat alterationsJohn R Koethe, Claire Lagathu, Jordan E Lake, et al.
The Journal of Infectious Diseases|August 16, 2021
Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular RiskAnna C Hearps, Thomas A Angelovich, Janine M Trevillyan, et al.
The Lancet. Microbe|August 19, 2023
Low prevalence of asymptomatic mpox in populations at high riskBenjamin Hampel, Andrea Farnham, Paul J Lamothe-Molina, et al.
Open Forum Infectious Diseases|March 9, 2016
Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort StudyLuigia Elzi, Anna Conen, Annalea Patzen, et al.
Pageof 42

Showing results (131-140 of 415) with videos related to

Sort By:
Pageof 42
AIDS (London, England)|September 16, 2015
The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIVPhilipp Kohler, Axel J Schmidt, Matthias Cavassini, et al.
BMC Infectious Diseases|July 8, 2017
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort studyDelphine Sculier, Angèle Gayet-Ageron, Manuel Battegay, et al.
AIDS (London, England)|November 21, 2007
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infectionHandan Wand, Alexandra Calmy, Dianne L Carey, et al.
AIDS (London, England)|November 30, 2020
Caring for people living with HIV during the global coronavirus disease 2019 pandemicOlivier Nawej Tshikung, Mikaela Smit, Annalisa Marinosci, et al.
American Heart Journal|December 17, 2019
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristicsFranck Boccara, Princy Kumar, Bruno Caramelli, et al.
AIDS and Behavior|June 2, 2011
Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysisOlivia Keiser, Ben Spycher, Andri Rauch, et al.
Nature Reviews. Disease Primers|July 4, 2020
Author Correction: HIV and antiretroviral therapy-related fat alterationsJohn R Koethe, Claire Lagathu, Jordan E Lake, et al.
The Journal of Infectious Diseases|August 16, 2021
Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular RiskAnna C Hearps, Thomas A Angelovich, Janine M Trevillyan, et al.
The Lancet. Microbe|August 19, 2023
Low prevalence of asymptomatic mpox in populations at high riskBenjamin Hampel, Andrea Farnham, Paul J Lamothe-Molina, et al.
Open Forum Infectious Diseases|March 9, 2016
Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort StudyLuigia Elzi, Anna Conen, Annalea Patzen, et al.
Pageof 42